Early Detection,
Better Outcomes.
Guided Therapeutics, Inc. (OTC: QB GTHP) is committed to developing groundbreaking medical devices using our patented biophotonic technology to detect diseases earlier, more accurately, and more efficiently than other tests.
Product Information
Our products are designed to improve the patient’s experience, provide the physician with more powerful tools, improve the efficiency of the healthcare system and increase shareholder value.
How we are making
a difference globally
Our products are designed to:
Improve the patient’s experience.
Provide the physician with more powerful tools.
Improve the efficiency of the healthcare system.
Technology
Our patented technology, which features our flagship product the LuViva® Advanced Cervical Scan, uses biophotonics to detect both physical and chemical changes in tissues that are early signs of cancer.
Investors
Cancer screening is a compelling market opportunity proven to save lives. As a pioneering company in this space, GTI represents an excellent investment.
Join our network of Investors
We are actively seeking new investors to join our network. We provide full transparency into our organization and would love to have you join.
We’re international and expanding. Read about Guided Therapeutics
Recent Press Releases
Guided Therapeutics Provides Updates on FDA Application Study Results, 2025 Earnings Increase and Successful Warrant Offering
March 31, 2026
Analysis of Guided Therapeutics' FDA Study Data Reveals Compelling Clinical Need for LuViva
December 17, 2025
Guided Therapeutics Receives $88,000 Payment as Third Installment of $700,000 Purchase Order with Chinese Distributor
December 11, 2025
Guided Therapeutics Inks Initial $200,000 Deal with New Distribution Partner Yuanshuo Medical Instruments Corporation
November 19, 2025